Pegaspargase
Showing 101 - 125 of 149
Leukaemia,Lymphoblastic Trial in GuangZhou (Vincristine, Daunorubicin, Pegaspargase)
Unknown status
- Leukaemia,Lymphoblastic
- Vincristine
- +12 more
-
GuangZhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jun 16, 2017
Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Houston (Daunorubicin, Vincristine, PEG-asparaginase)
Completed
- Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Daunorubicin
- +9 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 21, 2019
Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type Trial in China (chemo followed by radiotherapy, radiotherapy followed by
Unknown status
- Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
- chemotherapy followed by radiotherapy
- +2 more
-
Beijing, China
- +4 more
Jan 1, 2018
Lymphoblastic Leukemia, Acute Trial in Memphis, Fort Worth (Prednisone, Dexamethasone, Vincristine, Daunorubicin, Doxorubicin,
Completed
- Lymphoblastic Leukemia, Acute
- Prednisone, Dexamethasone, Vincristine, Daunorubicin
- +5 more
-
Memphis, Tennessee
- +1 more
Sep 9, 2020
Hemophagocytic Lymphohistiocytosis Trial in Beijing (Pegaspargase, doxorubicin HCl liposome injection, etoposide)
Unknown status
- Hemophagocytic Lymphohistiocytosis
- Pegaspargase
- +5 more
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Sep 21, 2016
Body Mass Index in Younger Receiving Treatment for High-Risk
Withdrawn
- Acute Lymphoblastic Leukemia
- Untreated Childhood Acute Lymphoblastic Leukemia
- Daunorubicin Hydrochloride
- +4 more
-
Philadelphia, PennsylvaniaChildrens Oncology Group
Aug 3, 2018
Recurrent Childhood Acute Lymphoblastic Leukemia Trial in Worldwide (L-asparaginase, doxorubicin HCl, therapeutic
Completed
- Recurrent Childhood Acute Lymphoblastic Leukemia
- L-asparaginase
- +13 more
-
Birmingham, Alabama
- +45 more
Nov 14, 2017
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in United States (pegcrisantaspase)
Terminated
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
-
Phoenix, Arizona
- +42 more
Mar 6, 2017
Hemophagocytic Lymphohistiocytosis Trial in Beijing (Pegaspargase, doxorubicin, etoposide)
Unknown status
- Hemophagocytic Lymphohistiocytosis
- Pegaspargase
- +3 more
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Aug 3, 2016
Extranodal NK/T-cell Lymphoma, Nasal Type Trial in Guangzhou (High dose of methotrexate, Gemcitabine, Pegaspargase)
Unknown status
- Extranodal NK/T-cell Lymphoma, Nasal Type
- High dose of methotrexate
- +3 more
-
Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat-Sen University Cancer Ce
Jun 11, 2016
Lymphoma, Extranodal NK-T-Cell Trial in Guangzhou (GELOX, IFRT)
Unknown status
- Lymphoma, Extranodal NK-T-Cell
- GELOX
- IFRT
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center; State Key Laboratory of On
Apr 18, 2016
Leukemia Trial (SC-PEG E. coli L-asparaginase, cytarabine, daunorubicin HCl)
Completed
- Leukemia
- SC-PEG E. coli L-asparaginase
- +7 more
- (no location specified)
Feb 19, 2016
Non-hodgkins Lymphoma, Hodgkins Lymphoma, Multiple Myeloma Trial in Hershey (Oncaspar, Doxil, Decadron)
Terminated
- Non-hodgkins Lymphoma
- +2 more
- Oncaspar, Doxil, Decadron
-
Hershey, PennsylvaniaPenn State Milton S. Hershey Medical Center
Jun 23, 2017
Acute Lymphoblastic Leukemia Trial in Worldwide (PEG Asparaginase at six weeks interval, PEG Asparaginase at two weeks interval)
Completed
- Acute Lymphoblastic Leukemia
- PEG Asparaginase at six weeks interval
- PEG Asparaginase at two weeks interval
-
Copenhagen, Denmark
- +5 more
Apr 20, 2017
B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic
Completed
- B-cell Childhood Acute Lymphoblastic Leukemia
- +3 more
- vincristine sulfate
- +12 more
-
Birmingham, Alabama
- +172 more
Apr 5, 2017
Ovarian Tumors, Fallopian Tube Tumors, Primary Peritoneal Tumors Trial run by the NCI (Pegylated L-Asparaginase)
Completed
- Ovarian Neoplasms
- +2 more
- Pegylated L-Asparaginase
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 8, 2015
Leukemia, Lymphoma Trial in United States (biological, drug, radiation)
Completed
- Leukemia
- Lymphoma
- dactinomycin
- +14 more
-
Los Angeles, California
- +6 more
Jan 25, 2016
Nasal and Nasal-type NK/T-cell Lymphoma Trial in Zhengzhou (DDGP(cisplatin,dexamethasone,gemcitabine,pegaspargase),
Unknown status
- Nasal and Nasal-type NK/T-cell Lymphoma
- DDGP(cisplatin,dexamethasone,gemcitabine,pegaspargase)
- +4 more
-
Zhengzhou, Henan, ChinaOncology Department of The First Affiliated Hospital of Zhengzho
Jul 15, 2015
Nasal and Nasal-type NK/T-cell Lymphoma Trial in Zhengzhou (DDGP(cisplatin,dexamethasone,gemcitabine,pegaspargase), Modified
Unknown status
- Nasal and Nasal-type NK/T-cell Lymphoma
- DDGP(cisplatin,dexamethasone,gemcitabine,pegaspargase)
- Modified SMILE （MTX，DEX，IFO，L-ASP，Etoposide，Mesna）
-
Zhengzhou, Henan, ChinaOncology Department of The First Affiliated Hospital of Zhengzho
Jul 15, 2015
Acute Lymphoblastic Leukemia Trial in Boston (Prednisone, Vincristine, Doxorubicin)
Completed
- Acute Lymphoblastic Leukemia
- Prednisone
- +8 more
-
Boston, Massachusetts
- +2 more
Feb 10, 2017
Leukemia, Lymphocytic, Acute Trial in Houston (Methotrexate, Vincristine, PEG-l-asparaginase)
Completed
- Leukemia, Lymphocytic, Acute
- Methotrexate
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 9, 2015